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Summary.-Antigenic determinants ofp30, the most abundant internal virion protein
of C type RNA viruses, were detected on the surface of spleen cells from mice bearing
Moloney leukaemia and on an in vitro line of Moloney sarcoma, MSC. On both cell
types, these determinants on the p30 molecules served as cytotoxic targets in a
xenogeneic complement dependent antibody mediated 51Cr release assay. Two
antisera were used: a rat anti MLV-M induced lymphoma serum, and an antiserum
raised in goats to ether disrupted FeLV. The cytotoxic target antigens of these
antisera were analysed by inhibition of cytotoxicity with viral and cellular proteins.
p3Ot is the most abuindant internal
protein of murine leukaemia and sarcoma
viruses (MLV, AMSV), since it comprises
30%o of the total viral protein (Gilden,
Oroszlan and Huebner, 1971). It has a
molecular weignt of approximately 30,000
daltons and is thought to be associated
with-t the core shell of thevirus (Bolognesi,
Luftig and Shaper, 1973). Both type and
group specific (gs) antigenic determinants
have been identified on the p30 molecule
(Gilden et al., 1971; Parks and Scolnick,
1972; Strand and August, 1974). The gs
determinants have beenfurthersubdivided
into a species specific (gsl) and an inter-
species specific determinant (gs3) (Gilden
et al., 1971).
Yoshiki, Mellors and Hardy (1973),
using indirect membrane immunofluores-
cence, detected a common cell surface
antigen associated with murine and feline
C type RNA leukaemia viruses in cells
infected or transformed by such viruses.
In these studies the authors employed an
antiserum prepared by the immunization
of rabbits with ether disrupted feline
leukaemia virus (FeLV). They suggested
that the common cell surface antigen
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which they detected with this antiserum
was p30, since this antigen was the only
subviral component to absorbtheantibody
activity against the common cell surface
antigen. In further immunofluorescence
studies both the gs1 and gs3 antigenic
determinants were detected on the surface
of leukaemic cells and tissue culture lines
infected with C type RNA viruses (Yoshiki
et al., 1974).
Further evidence that p30 is expressed
on the surface of mouse leukaemia cells
has been obtained from experiments using
xenogeneic cytotoxicantisera. Serumfrom
guinea-pigs hyperimmunized with pure
p30 is cytotoxic, in the presence of
complement, for mouse cells infected with
either Radiation leukaemia virus, or the
Gross and Moloney strains of MLV, but
not for the nonviral mnouse leukaemia
ERLD (Ferrer, 1973).
Although mice do not produce anti-p30
antibodies (Geering, Old and Boyse, 1966),
there is evidence that immune mouse
lymphocytes recognize the antigen. Thus,
p30 inhibits cell mediated cytotoxicity
towards MLV target cells (Gorczynski and
Knight, 1975a) and can stimnulate blast
transformation by MSV immune
lymphocytes (Knight and Gorczynski,
1975). Furthermore, lymphoid cells acti-
vated in vitro to p30 are able, on adoptive
transfer, to reduce the number of lethal
MSV tumours in sublethally irradiated
syngeneic recipient mice (Gorczynski and
Knight, 1975b).
The purpose of the present study was
to compare the expression of the gs1 and
gs3 antigenic determinants of p30 on
mouse cells infected or transformed by
MLV or MSV, using a xenogeneic cyto-
toxic antibody assay. The identification
of p30 in leukaemic mouse sera and the
relevance of circulating p30 to the tumour
status of the animal are discussed in the
following paper by Epstein and Knight
(1975). The results obtained here confirm
and extend those previously reported
with MLV-G induced lymphomata in
the rat (Knight, Mitchison and Shellam,
1975).
MATERIALS AND METHODS
Mice.-3-4 week oldnonspecificpathogen-
free female BALB/c mice were obtained from
the ICRF breeding unit at Mill Hill. They
were employed in these studies at 5-7 weeks
of age after evidence was observed of
successful intradermal scarification with
reconstituted Lister Institute smallpox
vaccine.
Tumours
1. Moloney leukaemia.-Spleen cells from
BALB/c mice infected with MLV-M were
obtained from Dr Robert Seeger and injected
intraperitoneally (i.p.) into newborn BALB/c
mice. Thereafter the tumour was passaged
in BALB/c mice at weekly intervals by i.p.
injection of 107 viable leukaemic spleen cells.
For use as targets in the cytotoxic assay,
erythrocytes in leukaemic spleens were lysed
by Tris buffered ammonium chloride as
described by Boyle (1968). 51Cr labelling of
spleen cells taken 7, 8, 12 or 19 days after
passage of the leukaemia was performed in
Hepes buffered MEM with 10% FCS as
described previously (Knight et al., 1975).
2. MSC line.-MSC is the designation for
an in vitro line of cells developed at NIH
and derived from an MSV-M induced sarcoma
from BALB/c mice (Massicot, Woods and
Chirigos, 1971). It was obtained for these
studies from Dr Robert Seeger who originally
obtained the line from Dr M. A. Chirigos at
NIH. Both round and fibroblastoid types of
cells are seen in MSC cultures. MSC is a viral
transformed line as evidenced by loss of
contact inhibition and its ability to form
colonies in soft agar (Massicot et al., 1971).
Large amounts of MSV-M are released from
the cultures. The cells were maintained in
25 ml Falcon plastic tissue culture flasks in
E-4-G1 with 10% heat inactivated FCS in a
CO2 incubator and passaged every 3-4 days.
For use in the cytotoxic assay, cells were
removed from the flasks by treatment at
37°C with0-02% versene in pH 7.2 phosphate
buffered NaCl (PBS) pH 7.2, washed twice
with warm Earle's saline, and then resus-
pended at 1 x 107 viable cells/ml in Hepes
buffered MEM with 10% FCS in preparation
for 51Cr labelling.
Complement
Rabbit complement was prepared as des-
cribed previously (Knight et al., 1975), and
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diluted 1: 3, making the final dilution in the
assay of 1: 9.
Antisera
1. Rat ILR-3.-This antiserum was pre-
pared in W/Fu rats against syngeneic
MLV-M induced-lymphoma cells as described
previously (Knight et al., 1975). On Ouch-
terlony gel diffusion a precipitin line was
formed with this antiserum and p30, and with
disrupted MLV-M, but not with hamster
sarcoma virus (HSV).
2. Goat Anti-gs3.-This antiserum was
prepared in goats against a preparation of
ether disrupted FeLV. It was a gift from
Professor William Jarrett, University of
Glasgow, Glasgow. Additional details of its
preparation and characterization have been
described previously (Jarrett et al., 1973;
Knight, Mitchison and Shellam, 1975). This
antiserum gave a line of identity not only
with ether disrupted FeLV, but also with
similar preparations of HSV and MLV on
Ouchterlony gel diffusion. Hence it is
primarily directed against gs3 or the inter-
species determinant of p30.
3. Rat anti-formol MSV-M.-MSV-M was
treated for 2 weeks at 5°C with 0.1% formal-
dehyde and then dialysed exhaustively
against phosphate buffered saline for 1 week.
50 lug of the formalinized virus was injected
i.p. into adult W/Fu rats every week for 3
weeks and the animals were bled 10 days
after the last injection. This antiserum is
virus neutralizing and therefore recognizes
the viral envelope antigen (VEA). It does
not react with purified p3O on Ouchterlony
gel diffusion.
4. Moloney sarcoma virus regressor serum.
-This serum was obtained from Dr Robert
Seeger. It was obtained from BALB/c mice
4 weeks after regression of a MSV-M induced
sarcoma. Additional sera were prepared in
BALB/c mice against MLV-M induced leu-
kaemias from C3H mice and absorbed with
normal C3H lymphoid tissue. All antisera
were heat inactivated at 560C for 30 min and
stored in small aliquots at -20° before use in
the cytotoxicity assay.
Materials usedfor absorption ofantisera
1. Viruses.-Intact MSV, of the Moloney
(M) or Gross (G) pseudo-type and intact
MLV-G were propagated in tissue culture,
purified by differential centrifugation and
isopycnic centrifugation in sucrose and then
dialysed against PBS as described previously
(Knight and Gorczynski, 1975). Because of
sensitivity of viral particles to freezing and
thawing, it is possible that intact virus
preparations also contain some internal virion
proteins. Newcastle Disease virus (NDV)
was a gift from Dr J. Skehel, National
Institute of Medical Research, Mill Hill,
London, England. Disrupted virus prepara-
tions were prepared either by 12 cycles of
repeated freezing and thawing, or by Triton
X-100 treatment followed by partition in
ether as previously described (Knight and
Gorczynski, 1975). The amount of protein
was determined by the method ofLowry et al.
(1951), or by the ratio of optical density at
280/260 nm using u.v.
2. p3O.-p30 was prepared by an iso-
electric focusing method described previously
(Scolnick, Parks and Livingston, 1972). The
purified material was at least 97% pure as
judged by polyacrylamide gel electrophoresis.
The mean molecular weight of 5 such pre-
parations, estimated from gel electrophoresis
was 32,500.
3. Extracts of viral infected cells.-Cell
extracts of MSV-M and MSV-G infected lines
of Theiler's original (To) mouse embryo fibro-
blasts were prepared by the hypertonic KCI
technique described by Meltzer et al.(1971).
4. Leukaemic and normal BALB/c spleen
cell preparations.-Single cell suspensions
were prepared from pools of2-3 leukaemic or
normal animals, by teasing, filtration through
stainless steel mesh and twice washing with
E-4-G1. The cells were packed at 1500 rev/
min for 10 min for use in absorption of
antisera.
5. Methodofabsorption.-Varyingamounts
of the absorbents, i.e. either intact or
disrupted virus, purified viral antigens, or
KCI extracts of viral infected cells, were
combined with the undiluted antisera to be
absorbed, and sufficient E-4-G1 with 10%
normal serum to make a final volume of
0-1 ml. This would result in the dilution of
the antiserum desired for use in the cyto-
toxicity assay. Consequently, in most in-
stances, 10-20 ,u of antiserum were used,
10-70 ,ul absorbent, and the remainder was
E-4-G1. The mixtures were maintained at
room temperature for 30 min and then used
in the cytotoxicity assays. Control pre-
parations containing only the absorbents and
on antisera were also included to exclude any
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possible cytotoxic or anticomplementary
effects of the absorbents.
When antisera were absorbed with normal
or leukaemic spleen cells, in some instances
250 ,ul of 1/5 dilutions of antisera were com-
bined with 50 pl packed cells and incubated
at 3700 for 30 min on a rotator. The cells
were then pelleted at 2000 rev/min for
4 min. The procedure was repeated for a
second absorption. On other occasions a
fixed number of leukaemic or normal spleen
cells was employed for the absorptions.
Cytotoxicity assay
1. 5'Cr labelling.-The technique em-
ployed was that described by Knight et al.,
(1975) withthefollowingmodification. 1 x 108
viable spleen cells from Moloney leukaemia
bearing mice, or 1 x 107 viable MSC cells
were suspended in 1 ml of Hepes buffered
MEM with 10% heat inactivated FCS in
30 mm plastic Petri dishes and incubated
with 100 ,Ci of 5'Cr (as Na chromate in
aqueous solution: specific activity of250 /Ci/
,ug, The Radiochemical Centre, Amersham)
at 3700 for 1 h with gentle agitation on a
rocking platform. The cells were spun at
1000 rev/min and washed 3 times with 40 ml
offresh media. The labelled spleen cells were
resuspended at 5 x 106 viable cells/ml and
the labelled MSC cells at 1 X 106 viable
cells/ml.
2. Assay.-The assay was performed in
2 x i in glass tubes (United Glass London),
as described previously (Knight et at., 1975).
Serial dilutions (0-1 ml) of antisera to be
tested were made in E-4-G1 media containing
10% heat inactivated normal serum of the
same species from which the antiserum was
derived. To this was added either 0.1 ml of
the 51Cr labelled spleen cells (5 X 105) or
MSC cells (1 X 105), and 0-1 ml rabbit com-
plement diluted 1: 3 with E-4-G1. The
following controls were included in each
assay: (1) 51Cr labelled cells and 0-2 ml
E-4-G1 to determinetotal amountoflabel and
amount of spontaneous release; (2) 6lCr
labelled cells plus 0-2 ml5% Brij 35 (polyoxy-
ethylene lauryl ether, BDH Chemicals Ltd,
Poole, England) to determine maximum
release of label by detergent release; (3) 5'Cr
labelled cells plus rabbit complement and
10% normal serum in E-4-G1, without anti-
serum, to determine the extent of the
background cytotoxicity of the complement
itself; (4) 51Cr labelled cells plus either rabbit
complement or 10% normal sera without
antisera to study the selective effect of either
the complement or the diluent used for
antisera on the target cells.
The tubes were incubated for 45 min at
370C in a 5% C02 atmosphere. After
incubation, 1 ml of cold Earle's saline was
added to each tube and all tubes except those
under study for total 51Cr labelling were
centrifuged at 5°C for 5 min at 2000 rev/min.
Supernatants were decanted and counted on
a Wallac Gamma Counter (Model GTL 300,
Wallac, Turku, Finland).
In some instances a 2-step assay was
performed, in which cells and dilutions of
antisera being absorbed with various sub-
stances were incubated alone at 370C for 30
min before the addition ofrabbit complement
and then incubated for an additional 30 min
at 37°. Such samples were runin this manner
to minimize any anti-complementary effects
of the absorbents.
For these studies % specific cytotoxicity
was defined as follows:
% specific - ctfminAb+c-ct/minNs+C
cytotoxicity ct/minBrij - Ct/minNs+C
where
ct/min Counts per min in tubes containing the
following substances:
Ab = Various dilutions of a given antiserum
C = rabbit complement
NS - 10Y normal serum, used as diluent
Brij = detergent, i.e. maximum release of
counts.
To determine the extent to which a given
substance will absorb antibody activity, i.e.
block complement dependent antibody
mediated cytotoxicity, the following formula
was employed.
Y. specific % specific
% block=cytotoxicityAb-cytotoxicityAb+y x 100
/ specific CytOtOXiCityAb
where
Ab = Various dilutions of a given anti-
serum
Ab + Y = various dilutions ofa given antiserum
in the presence of absorbent, Y.
RESULTS
Complement dependent cytotoxicity of Rat
ILR-3
The graph in the left portion of Fig. 1
depicts the results of 4 experiments which
show that Rat ILR-3 serum contains
antibodies which are cytotoxic for M
leukaemic spleen cell targets in the
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FIG. 1.-Complement dependent % specific cytotoxicity of Rat ILR-3 for M leukaemia spleen cell and
MSC targets. The symbols indicate either days after passage of leukaemia in vivo or passage of
cells in vitro.
For experiments on M targets, 0 and 0 were from the same group of animals studied 7 and
12 days after passage of leukaemia; O and a were studied on the same day, but each originated
from a separate group of animals, distinct from that depictedl with 0 and 0. For experiments
on MSC targets, 0, 0 and O were studied sequentially, from the same passage. * indicates a
separate passage, distinct from 0-].
A negative value indicates that there was less 5'Cr release than in the control tubes containing
10/ normal rat serum and rabbit complement, but still more than the spontaneous release.
presence of rabbit complement. Pre-
liminary experiments had shown that
greater % specific cytotoxicity was
achieved with this antiserum and rabbit
complement than with guinea-pig com-
plement. The % cytotoxicity of Rat
ILR-3 for M targets observed in these
experiments are in good agreement with
similar experiments performed by Knight
et al. (1975). For a given experiment the
mean difference between the calculated
%0 specific cytotoxicity of duplicate sam-
ples was 6%0. In no instance was the
difference between the replicates greater
than 150%
If the data from all 4 experiments are
pooled, of the total 51Cr label, 20 ± 3.2%
ofthe counts were released spontaneously,
62 ± 5*O were released by detergent,
and 35 ± 4.6% were released by 10%
normal rat serum and rabbit complement.
Slight variation in response was observed
from one group ofanimals to another, but
in general these and other similar experi-
ments suggested that for a given group of
animals the 0% specific cytotoxicity at
lower dilutions of Rat ILR-3 was greater
with 7 and 12 day targets than with
19 day cells.
The data depicted on the right side of
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FIG. 2. Complement (lependent °0 specific cytotoxicity of Rat ILR-3 for Ml letukaemia spleeni cell
targets before and after absorption with either M leukaemia spleen cells or normal spleen cells from
BALB/c mice. * non absorbed, A absorbed x 1 with normal cells, A absorbed x 2 with
normal cells, absorbed x 1 with AM leukaemia cells, * absorbed x 2 with Ml leukaemia cells.
Leukaemia cells used for absorptions were obtained 7 days after passage of letukaemia and
absorptions were carried out as (letailedc in Materials andI AMethods. A negative value indicates that
there was less 51Cr release than in the control tuibes containing 100% normal rat serum andl rabbit
complement, but still more than the sponitanieous release.
Fig. 1 are from 4 representative experi-
ments and demonstrate that ILR-3
containsantibodieswhicharealsocytotoxic
for MSC targets in the presence of rabbit
complement. With these target cells, of
the total 5'Cr label, spontaneous release
amounted to 11 ± 5.4%0, detergent release
65 ± 6.5% (with the exception of cells
studied one day after passage, where
detergent release accounted for only 18%
of the total 51Cr label), and 10% normal
rat serum and rabbit complement ac-
counted for 14 i 166% (again with excep-
tion of cells studied one day after passage,
where the value was only 4%0).
Absorption studies with Rat ILR-3
To identify the antigenic determinants
which served as targets for the confple-
ment dependent cytotoxic antibodies in
Rat ILR-3, several absorption studies
were performed. Figure 2 depicts the Qo
specific cytotoxicity of Rat ILR-3 for M
leukaemic spleen cell targets before and
after one and 2 absorptions with either
normal spleen cells or M leukaemic spleen
cells obtained from BALB/c mice. The
data indicate that M leukaemic spleen
cells did absorb the cytotoxic antibody
activity, partially by the first and com-
pletely by the second absorption. In
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F'ie. 3. % block of antibo(ly ie(liated cytotoxity of Rat ILR-.3 for M leutkaemia spleen cell
targets by intact a(l * disrupte(l MSV-M virus. * intact MSV-MA, 0 (lisrupte(d MSV-M.
Values observed above 100% block indicate that the absorbents had protective effect not oinly
against cytotoxicity of the antiserum tested, but also against the cytotoxicity imparte(l by rabbit
complement as; -well. Leuikaemic cells obtained 12 days after passage of leukaemia employed in
these stu(lies.
contrast, normnal BALB/c spleen cells
were ineffective in absorbing the cytotoxic
antibody, even after 2 absorptions. This
indicates, therefore, that the cytotoxic
antibody or antibodies present in ILR-3
are directed to components on the surface
ofM leukaemic spleen cellsthataredistinct
from that seen on normal spleen cells, and
which are therefore related to leukaemic
associated antigens.
Subsequently, absorption studies on
Rat ILR-3 were performed with intact
and disrupted AISV-M virus preparations.
The data from a representative experiment
using M leukaemic spleen cell targets are
shown in Fig. 3 and indicate that both
intact and disrupted viral preparations
can absorb cytotoxic antibodies from Rat
ILR-3. As little as 28 ,ug protein of
disrupted virus and 35 Itg protein ofintact
virus block 100% of the reaction. This
suggests that ILR-3 contains cytotoxic
antibodies against both internal and
external virion antigens.
To determine the specificity of the
viral block, virus unrelated to the C type
RNA viruses was also employed in similar
Rat ILR-3 absorption studies, but with
MSC cells as targets. One representative
experiment is depicted in Fig. 4. It is
apparent that for MSC targets as well as
for M leukaemic spleen targets, that only
a small amount of MSV-M protein (10 ,lg)
can result in greater than 9000 block ofthe
cytotoxic activity of ILR-3. Weight for
weight, MSV-M was 1000 times as efficient
in blocking as NDV. Extrapolation ofthe
data obtained with NDV indicates that
> 10 mg of NDV would be required to
produce inhibition equivalent to that
produced by 10 pig of MSV-M.
The block of cytotoxic activity of
ILR-3 for MSC targets was not unique for
MSV-M, however. Other related C type
RNA viruses, MSV-G and MLV-G, as well
as KCI extracts of mouse embryo tissue
culture lines infected with MSV-G and
MSV-M, could absorb the cytotoxic anti-
bodies in Rat ILR-3, and the data are
depicted in Fig. 5. In these experiments,
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FIG. 4.-° block ofantibody mediated cytotoxicity of Rat ILR-3 for MSC targets by intact MSV-M
and NDV virus.
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FIG. 5.-% block ofantibody mediated cytotoxicity ofRat ILR-3 for MSC targets by intact MSV-M,
MSV-G, MLV-G and KCl extracts of mouse embryo tissue culture lines infected with MSV-G or
MSV-M.
100% block was obtained with 8,ug of
MSV-M or MSV-G and < 12 ,ug MLV-G.
If the data obtained using KCI extracts
are extrapolated to 100%, 160lug of
MSV-M infected and 240,ug of MSV-G
infected preparations were required.
Therefore, weight for weight, 20-30 times
as much KCI extract ofvirus infected cells
were required for 100% block, than intact
virus.
Cytotoxicity studies with monospeciftc anti-
sera
To confirm the presence of specific
viral antigens on the surface of the M
leukaemia spleen cell and MSC targets,
monospecific antisera were employed.
Figure 6 depicts the results of 2 experi-
ments in which the % specific cytotoxicity
of rat anti-formol MSV-M serum for M
leukaemia spleen cell targets was studied.
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FIG. 6.-Complement dependent % specific cytotoxicity of rat anti-formol MSV-M for M leukaemia
spleen cell targets 7 and 12 days after passage of leukaemia.
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FiG. 7.-Complement dependent % specific cytotoxicity of goat anti-gs3 for MSC targets.L. B. EPSTEIN AND R. A. KNIGHT
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Fie. 8.-Complement dependent % specific cytotoxicity of goat anti-gs3 for M leukaemia spleen cell
targets before and after absorption with normal or leukaemic spleen cells. * non-absorbed,
0 absorbed with the number of cells indicated. The first 3 panels represent absorptions with
leukaemic cells taken after passage of the leukaemia at the time indicated. The far right panel
represents the absorption with normal spleen cells.
In the presence of rabbit complement,
cytotoxicity was observed against cells
obtained 7 and 12 days after passage
of the leukaemia, but higher dilutions
of the antiserum were more cytotoxic
for the Day 7 cells than for the Day 12
cells.
In subsequent experiments, antisera
directed against internal virion proteins
were studied. Figure 7 illustrates a repre-
sentative experiment in which goat anti-
gs3 was shown to be cytotoxic for MSC
target cells in the presence of rabbit com-
plement. Goat anti-gs3 was also cytotoxic
for M leukaemia spleen cell targets,
although to a lesser degree than was
observed with MSC targets. For example,
in 4 experiments with M targets the mean
% cytotoxicity at a dilution of 1/5 was
16%; at 1/10, 13%; at 1/20, 11%, at
1/40, 1%. A comparison was then made
between the % specific cytotoxicity ob-
served before and after absorption of the
goat anti-gs3 with either normal BALB/c
spleen cells or M leukaemia spleen cells,
the latter obtained at 4, 8 and 12 days
after the passage of the leukaemia. The
results, shown in Fig. 8, indicate that
spleen cells obtained from the leukaemic
animals could absorb out the anti-gs3
cytotoxic antibodies, but that normal
spleen cells could not. It was of interest
to note that spleen cells obtained 8 days
after the passage of leukaemia were
superior to those obtained either after 4 or
12 days, as in the former instance most of
the anti gs3 activity was absorbed with
only 105 cells, whereas in the latter 2
instances more cells were required.
Absorption studies with purified viral
proteins
Several experiments were performed
to substantiate the role of p30 as a cyto-
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TABLE.-Fffect ofAbsorption ofAntisera with Viral Protein on % Specific Cytotoxicity
Antiserum
MSC targets
Rat ILR-3
M leukaemiia targets
Rat ILR-3'
Rat anti-formol
MSV-M
Amount
used for
Dilution Viral absorption
absorbed protein (Mg)
1/10
1/5
1 '20
p30
p30
p30
0-18
1 *8
3-6
9 0
12 -6
3-1
3-6
* °/0 specific cytotoxicity and % block are calculated as described in Materials and Methods.
t Values expressed are th-e means ofduplicate determinations. In these experiments the mean difference
between the calculated % specific cytotoxicity of duplicate samples was 5 ± 3 %. In no instance was the
difference between the replicates greater than 8 %.
toxic target on MSC and M leukaemia
spleen cell targets and they are sum-
marized in the Table. Absorption of Rat
ILR-3 with as little as 0-18 jg of p30
resulted in 43% block of the cytotoxic
activity ofthe antiserum. Yet, increasing
the amount ofp30 used for the absorption
by 70-fold, i.e. to 12-6 6,g still did not
result in 100% absorption of cytotoxic
activity.
Absorption of ILR-3 antibody with
3-6 ,ug p3U produced 64% block of cyto-
toxicity against MSC targets. However,
the same amount ofantigen inhibited lysis
of M leukaemia spleen cell targets by
ILR-3 by only 16%. On both cell
targets ILR-3 is recognizing p30, although
it would appear that even on MSC cells its
cytotoxicity is not directed exclusively to
this antigen.
The goat anti-gs3 antiserum was cyto-
toxic for both MSC and M leukaemia cell
targets, although the % specific cytotoxi-
city of leukaemic cells was low. Corres-
pondingly, as little as 0-18 ,ug purified p30
totally absorbed cytotoxicity against leu-
kaemic cells, whereas only 20% of the
cytotoxicity against MSC cells was ab-
sorbed by 9-0 ag purified p30.
p30 was not effective in absorbing
cytotoxic activity of rat anti-formol
MSV-M, suggesting that the absorption of
other antisera by p30 is a specific event.
The cytotoxicity of the rat anti-formol
MSV-M confirms the presence ofcytotoxic
targets other than p30 on the surface of
leukaemic cells.
To rule out further the possibility of
nonspecific absorption, i.e. that any pro-
tein, if in large enough amounts could
absorb out cytotoxic antibody activity, a
parallel experiment using Rat ILR-3
(absorbed with amounts of albumen
varying from 30 ,ug to 6 mg) against MSC
targets was run. Absorption by albumen
was noted only with 6 mg, an amount far
in excess ofthe amount of viral or cellular
protein used in our other blocking studies.
Cytotoxicitystudies with MSV regressor sera
In 4 experiments using MSC targets,
with either guinea-pig complement or
rabbit complement, and using 2 separate
BALB/c MSV regressor sera neat, and in
doubling dilutions to 1/640, no cytotoxic
activity was noted. Similar negative
findings were observed when M leukaemia
spleen cells were employed as targets with
the antiserum prepared in BALB/c mice
against C3H MLV-M induced leukaemia.
This result was not unexpected as mouse
sera are thought not to recognize p30.
DISCUSSION
Spleen cells from mice bearing Moloney
leukaemia were chosen for study in these
experiments because they represent cells
% Specific
before
absorption
42t
42
42
42
42
69
15
Cytotoxicity*
after
absorption
24
17
15
11
7
58
18
% Block
43
59
64
74
83
16
0
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infected by C type RNA viruses taken
from an in vivo environment in which host
defence mechanisms come into play. By
contrast, MSC cells, also chosen for study,
represent a cell type or types transformed
by such viruses, and taken from an in vitr-o
environment without benefit of host
defence mechanisms other than those
inherent in the cells themselves.
The present study demonstrates that
p30, the most abundant internal virion
protein of C type RNA viruses, is asso-
ciated with the surface on both these cell
types, in that group specific antigenic
determinants on the p30 molecule were
shown to act as cytotoxic targets in
xenogeneic complement dependent anti-
body mediated cytotoxicity reactions.
For this study we employed an anti-
serumn prepared in rats against a syngeneic
AILV-MI lymphoma (ILR-3) and one
prepared in goats against an ether dis-
rupted preparation ofFeLV (goatanti-gs3).
Absorption of each of these antisera with
normal BALB3c mouse spleen cellsresulted
inl no loss of cytotoxic activity, thus
indicatinig that the cytotoxic antibodies
present in these sera were directed to
antigenic determinants other than those
found on normal murine cells. This
observation, coupled with the fact that
absorption ofeach antiserumwithMoloney
leutkaemia spleen cells from age and sex
matched BALB/c mice resulte(I in com-
plete loss of cytotoxic antibody activity,
indicated that such antibodies were
directed toward leukaemia associated
antigens.
Further absorption studies with Rat
ILR-3 revealed the following information
about the cytotoxic antibodies contained
therein: (1) They were directed against
antigenic determinants associated with
oncogenic C type RNA viruses, but not
with non-oncogenic, unrelated RNA
viruses as siginificant absorption of cyto-
toxic antibody activity against MSC cells
was observed with intact MSV-M but not
with NDV. (2) They were directed against
antigenic determiinants of internal as well
as external proteins of AISV-NM, as both
disrupted, as well as intact viral prepara-
tionsofMSV-M absorbed cytotoxicactivity
directed against M leukaemia spleen cell
targets. (3) They were directed against
group specific antigenic determinants of
the C type RNA viruses as intact MSV-C
and MLV-G as well as MSV-M absorbed
cytotoxic activity directed against MSC
targets. (4) They were not hetero-
antibodies directed against murine histo-
compatibility antigens (which have been
shown on occasion to adhere to viral
envelopes (Aoki and Takahashi, 1972), as
MLV-G propagated in rat tissue culture
lines absorbed the cytotoxic activity of
ILR-3 as effectively as MSV-G and MSV-
M propagated in mouse tissue culture
lines. (5) They were directed against
group specific viralantigenicdeterminants,
which were intimately associated with the
surface membranes of cells infected with
C type RNA viruses, as KCI extracts of
whole mouse embryo cells infected with
either MSV-M or MSV-G absorbed cyto-
toxic antibody activity of ILR-3 against
MSC targets. (6) They were directed
against antigenic determinants of p30
obtained from MSV-M as highly purified
preparations of this protein were effective
in absorbing cytotoxic antibody activity
of ILR-3 against both M leukaemia spleen
cell and MSC targets.
Confirmatory evidence that p30 is
associated with the surface membranes of
both cell types was obtained with the goat
anti-gs3 serum. It was cytotoxic for both
cell types and its cytotoxic antibody
activity could be partially blocked by
purified preparations of p30. It is
possible that the antigenic determinants
of p30 are more abundant or more acces-
sible on the surface ofMSC cells than on M
leukaemia target cells, as there was more
specific cytotoxicity for the former than
the latter. Also, a given amount of p30
blocked the cytotoxicity ofthis antiserum
for M targets more readily than MSC,
despite the fact that 5 times as many Al
targets were employed as MSC. There is
also suggestive evidence that the amount
or accessibility of the anitigeniic deter-
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miinants of p30 on M target cells can
fluctuate, as a fixed number of leukaemic
cells obtained 8 days after inception ofthe
leukaemia were more effective atabsorbing
the cytotoxic activity of the goat anti-gs3
than those obtained either at Day 4 or
Day 12. However, in this situation it is
difficult to distinguish between the pre-
sence of more gS3 per cell or simply the
presence of more cells with gS3. It is
possible that the quantitative differences
between the expression of p30 antigenic
determinants on MSC and M cells, or on
AI cells with time are due to host modifica-
tion of antigen expression on the in vivo
targets.
It is unlikely that the presence of p30
on viral infected or transformed cells
represents simple adsorption of the viral
protein to the surface membranes of cells.
In the present study, target cells were
washed 4-5 times before use in the
cytotoxic assay and still the antigenic
determinants of p30 were detectable as
cytotoxic targets. Furthermore, Yoshiki
et al. (1973, 1974) have demonstrated with
immunoelectron microscopic techniques
that p30 is located on cell membranes near
the site ofvirus budding but at a locations
distinct from that of VEA. They then
showed with immunofluorescence that an
antigenic determinant of p30 can actually
cap with monospecific antisera, thus
indicating an intimate relationship of the
p30 molecule with the fluid membrane of
C-type RNA virus infected cells.
Despite the fact that considerable
cytotoxicity was observed in the present
study with the goat anti-gs3 for MSC cells,
we were unable to produce more than 14%
specific lysis of MSC cells or any lysis
of MI leukaemia spleen cells with a rab-
bit antibody raised to purified p30
an1d which recognized solely the gs, determinant.
It would appear then that in the
mouse differential expression of gs, and
gs3 antigenic determinants of p30 occurs.
This is not true for the rat, where the same
goat anti-gs3 and rabbit anti-gs, sera
employed in the present study gave equal
amounits of cytotoxicity when tested
against rat G lymphoma cells (Knight
et al., 1975).
The question still remains as to
whether Rat ILR-3 and goat anti-gs3
have cytotoxic antibodies to antigenic
determinants other than to those detected
on the p30 molecule. With the doses of
p30 used in this study, up to 830% of the cytotoxic activity of lLR-3
against MSC targets was absorbed but
only 16% of the activity against AM
targets was observed. There is no doubt
that other leukaemia associated antigens
are present on the surface of bothi target
cell types. Rat anti-formol MSV-M serum
was cytotoxic for the MSC cells and its
activity, directed primarily against VEA,
could not be blocked by p30. Similarly,
a minimal amount of block (10%) was
observed where ILR-3 was absorbed with
2 ,tg ofpure VEA (Epstein, Mitchison and
Knight, unpublished). In addition, intact
MSV-M was shown to absorb ILR-3
almost equally as well as disrupted
MSV-M. The disrupted virus preparations
contain approximately 100 times as much
p30 as intact virus. If the antigenic
determinants of p30 were the sole speci-
ficities recognized by ILR-3, one would
have expected better absorption with the
disrupted virus preparations.
Recently, Ferrer suggested that GCSA
(b), a serologically detected antigenic
determinant on the surface of Gross virus
induced lymphomata which is detected by
rat antisera but Inot bY mouse, is p30
(Ferrer, 1973).
The results of the present studv are in
agreement with this, as are our recent
studies which showed total block of the
cytotoxicity of rat anti-Gross lymphoma
sera for syngeneic target cells by p30
(Knight and Gorczynski, 1975; Knight
et al., 1975). A manuscript to follow also
offers confirmatory evidence, as in it we
demonstrate that Moloney leukaemic
serum contains p30 and also absorbs the
cytotoxic activity of Rat ILR-3 against
MSC and M target cells (Epstein and
Knight, 1975).
0111512 L. B. EPSTEIN AND R. A. KNIGHT
We gratefully acknowledge the expert
technical help of Jenny Bruce and Keith
Adams. We thank Professor N. A.
Mitchison for his advice and encourage-
ment. We are indebted to Carol Stadum
and Dorothy Metcalf for typing the final
manuscript.
REFERENCES
AOKI, T. & TAKAHASHI, T. (1972) Viral and Cellular
Surface Antigens of Murine Leukemias and
Myelomas. Serological Analysis by Immuno-
electron Microscopy. J. exp. Med., 135, 443.
BoLoGNEsI, D. P., LUFTIG, R. & SHAPER, J. H.
(1973) Localization of RNA Tumor Virus Poly-
peptides. Virology, 56, 549.
BOYLE, W. (1968) An Extension of the Cr-Release
Assay for the Estimation of Mouse Cytotoxins.
Tran8plantation, 6, 761.
EPSTEIN, L. B. & KNIGHT, R. A. (1975) Studies on
Mouse Moloney Virus Induced Tumours. II.
Detection of p30 in the Serum of Mice with
Moloney Leukaemia by in vitro Blocking of
Complement Dependent Antibody Mediated Cyto-
toxicity. Br. J. Cancer, 31, 513.
FERRER, J. F. (1973) Cell-surface and Virion-
envelope Antigens Shared by Radiation Leukemia
Virus (Rad LV) and other Murine C-type Viruses.
Int. J. Cancer, 12, 378.
GEERING, G., OLD, L. J. & BoYsE, E. A. (1966)
Antigens of Leukemias Induced by Naturally
Occurring Murine Leukemia Virus: Their Relation
to the Antigens of Gross Virus and other Murine
Leukemia Viruses. J. exp. Med., 124, 753.
GILDEN, R. V., OROSZLAN, S. & HUEBNER, R. J.
(1971) Coexistence ofIntraspecies and Interspecies
Specific Antigenic Determinants on the Major
Structural Polypeptide of Mammalian C-type
Viruses. Nature, New Biol., 231, 107.
GORCZYNSKI, R. M. & KNIGHT, R. A. (1975a) Cell
Mediated Immunity to Moloney Sarcoma Virus in
Mice. IV. Direct Cellular Cytolysis of5'Cr Labelled
Target Cells in vitro and Analysis of Blocking
Factors which Modulate Cytotoxicity. Br. J.
Cancer, 31, 387.
GORCZYNSKI, R. M. & KNIGHT, R. A. (1975b) Cell-
mediated Immunity to Moloney Sarcoma Virus
in Mice. II. Analysis of Antigenic Specificities
Involved in T-lymphocyte-mediated in vivo
Rejection of Murine Sarcoma Virus-induced
Tumors. Eur. ,J. Immunol. In the press.
JARRETT, W. F. H., JARRETT, O., MACKEY, L.,
LAIRD, H. M., HARDY, W. D. Jr. & ESSEX, M.
(1973) Horizontal Transmission of Leukemia
Virus and Leukemia in the Cat. J. natn. Cancer
Inst., 51, 833.
KNIGHT, R. A. & GORCZYNSKI, R. M. (1975) Cell
Mediated Immunity to Moloney Sarcoma Virus in
Mice. I. Analysis of Antigens Responsible for
Lymphocyte Stimulation in Regressor Mice.
Int. J. Cancer. 15, 48.,
KNIGHT, R. A., MITCHISON, N. A. & SHELLAM, G. R.
(1975) Studies on a Gross Virus-induced Lym-
phoma on the Rat. II. The Role of Cell Mem-
brane Associated and Serum p30 Antigen in the
Antibody and Cell-mediated Response. Int. J.
Cancer. In the press.
LOWRY, 0. H., ROSEBROUGH, N. J., FARR, A. L. &
RANDALL, R. J. (1951) Protein Measurement with
theFolin Phenol Reagent. J. biol. Chem., 193,265.
MASSICOT, J. G., WOODS, W. A. & CHIRIGOS, M. A.
(1971) Cell Line Derived from a Murine Sarcoma
Virus (Moloney Pseudotype)-induced Tumor:
Cultural, Antigenic and Virological Properties.
Appl. Microbiol., 22, 1119.
MELTZER, M. S., LEONARD, E. J., RAPP, H. J. &
BoRsos, T. (1971) Tumor-specific Antigen Solu-
bilized by Hypertonic Potassium Chloride. J.
natn. Cancer Inst., 47, 703.
PARKS, W. P. & SCOLNICK, E. M. (1972) Radio-
immuno Assay of Mammalian Type-C Viral
Proteins: Interspecies Antigenic Reactivities of
the Major Internal Polypeptide. Proc. natn.
Acad. Sci. U.S.A., 69, 1766.
SCOLNICK, E. M., PARKS, W. P. & LIvINGSToN,
D. M. (1972) Radioimmunoassay of Mammalian
Type C Viral Proteins. J. Immun., 109, 570.
STRAND, M. & AuGUST, J. T. (1974) Structural
Proteins of Mammalian Oncogenic RNA Viruses;
Multiple Antigenic Determinants of the Major
Internal Protein and Envelope Glycoprotein.
J. Virol., 13, 171.
YOSHIKI, T., MELLORS, R. C. & HARDY, W. D. JR
(1973) Common Cell-surface Antigen Associated
with Murine and Feline C-type RNA Leukemia
Viruses. Proc. natn. Acad. Sci. U.S.A., 70, 1878.
YOSHIKI, T., MELLORS, R. C., HARDY, W. D. JR &
FLEISSNER, E. (1974) Common Cell-surface
Antigen Associated with Mammalian C-type RNA
Viruses. J. exp. Med., 139, 925.